From De Novo Molecular Design to Experimentally Validated Protein-Protein Interaction Modulators

Identifying bioactive small molecules requires balancing target affinity with physicochemical and pharmacokinetic properties compatible with drug development. This is particularly challenging in the development of small-molecule modulators of protein–protein interactions (PPIs) due to the structural complexity of protein interfaces. Here, we developed an integrated workflow combining de novo molecular design with similarity-guided identification of existing compounds from public chemical libraries. We applied this strategy to neuronal calcium sensor-1 (NCS-1), a calcium-binding protein whose interactions with multiple partners regulate synaptic function, making it an attractive target for modulating neuronal signaling. REINVENT4-based molecular generation incorporated predicted binding to the NCS-1 hydrophobic crevice, synthetic accessibility, and CNS-relevant ADMET properties, including blood–brain barrier permeability. Generated structures guided the selection of commercially available analogues. Experimental validation supported the effectiveness of this AI-guided strategy: 11 of the 12 tested compounds bound NCS-1, including 5 with micromolar affinities. In situ protein–protein interaction assays further confirmed the modulatory activity of selected compounds, identifying, to our knowledge, the first small-molecule enhancers of the NCS-1/cannabinoid receptor 1 (CB1R) interaction. CB1R is an attractive pharmacological target implicated in neuronal signaling, whose activity is regulated by NCS-1. High-resolution crystal structures revealed how these modulators engage the NCS-1 hydrophobic crevice, providing structural insights into ligand recognition and suggesting a mechanism of action. These findings connect generative molecular design with experimentally accessible NCS-1 ligands and provide chemical tools and structural insights for investigating NCS-1-dependent regulation of CB1R.

Authors

Institutions

Publication Details

Journal
ChemRxiv
Published
2026-11-18
DOI
https://doi.org/10.26434/chemrxiv.15012413/v1
Primary Topic
Computational Drug Discovery Methods
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

From De Novo Molecular Design to Experimentally Validated Protein-Protein Interaction Modulators

Nuria Eugenia Campillo, Eugenia Ulzurrun, Óscar Toledano, Alicia Mansilla et al.
1 links
ChemRxiv
Computational Drug Discovery Methods
preprint

From De Novo Molecular Design to Experimentally Validated Protein-Protein Interaction Modulators

Nuria Eugenia Campillo, Eugenia Ulzurrun, Óscar Toledano, Alicia Mansilla, Lorena Aguado, María José Sánchez-Barrena, Paula Alonso-García, Celia Miró-Rodríguez
preprint en

Abstract

Identifying bioactive small molecules requires balancing target affinity with physicochemical and pharmacokinetic properties compatible with drug development. This is particularly challenging in the development of small-molecule modulators of protein–protein interactions (PPIs) due to the structural complexity of protein interfaces. Here, we developed an integrated workflow combining de novo molecular design with similarity-guided identification of existing compounds from public chemical libraries. We applied this strategy to neuronal calcium sensor-1 (NCS-1), a calcium-binding protein whose interactions with multiple partners regulate synaptic function, making it an attractive target for modulating neuronal signaling. REINVENT4-based molecular generation incorporated predicted binding to the NCS-1 hydrophobic crevice, synthetic accessibility, and CNS-relevant ADMET properties, including blood–brain barrier permeability. Generated structures guided the selection of commercially available analogues. Experimental validation supported the effectiveness of this AI-guided strategy: 11 of the 12 tested compounds bound NCS-1, including 5 with micromolar affinities. In situ protein–protein interaction assays further confirmed the modulatory activity of selected compounds, identifying, to our knowledge, the first small-molecule enhancers of the NCS-1/cannabinoid receptor 1 (CB1R) interaction. CB1R is an attractive pharmacological target implicated in neuronal signaling, whose activity is regulated by NCS-1. High-resolution crystal structures revealed how these modulators engage the NCS-1 hydrophobic crevice, providing structural insights into ligand recognition and suggesting a mechanism of action. These findings connect generative molecular design with experimentally accessible NCS-1 ligands and provide chemical tools and structural insights for investigating NCS-1-dependent regulation of CB1R.

ChemRxiv
Consejo Superior de Investigaciones Científicas (ES), Universidad Nacional de Educación a Distancia (ES), Universidad de Alcalá (ES), Instituto de Química Física Blas Cabrera (ES), Centro de Investigaciones Biológicas Margarita Salas (ES), Hospital Universitario Ramón y Cajal (ES)
European Synchrotron Radiation Facility, Universidad Nacional de Educación a Distancia, Agencia Estatal de Investigación
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon